Allergan

First patients enrolled in dry eye device studyPatient recruitment has started in a randomised clinical trial testing an experimental device (Lamelleye, known also as CXB/1-14) for the treatment of dry eye disease (DED).
Phase 3 trials for acne treatment show promising resultsThe tetracycline-derived antibiotic sarecycline from Allergan plc and Paratek Pharmaceuticals Inc. for the treatment of moderate-to-severe acne has been found effective and safe, according to the results of two phase 3 trials.
Intense pulsed light bridges eye care and aestheticsWhat is this age-defying modern technology that a young, nonmedical professional is applying to her face? It is a YAG laser combined with an intense pulse light (IPL).
Aflibercept rivals laser for diabetic retinopathyIntravitreal aflibercept worked better than panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR) in a new head-to-head trial, according to researchers.
Preparing your patient for PRKPhotorefractive keratectomy (PRK) was the original excimer laser procedure approved by the FDA—and is still a safe and effective treatment of refractive errors. PRK has the benefits of no-flap creation; therefore, there is no risk of flap complications.
Understanding the link between MGD and OSDMeibomian gland dysfunction (MGD) may be misdiagnosed. While MGD is one of the most common chronic ocular conditions, diagnosing MGD isn’t as simple as it seems.
FDA Issues Warning for EluxadolineAnti-IBS drug Viberzi (eluxadoline) increases risk of severe pancreatitis.
6 challenges when changing from a group to private practice
6 challenges when changing from a group to private practiceA little over 18 months ago, I decided to follow my passion and take a leap of faith changing my career. I went from a bustling MD/OD group practice to a private group OD practice and launched the Dry Eye Center of Pennsylvania (PA).
Allergan to acquire CoolSculpting’s maker ZeltiqAllergan has announced that it has agreed to acquire ZELTIQ Aesthetics for $2.475 billion, a deal expected to close in the second half of the year.
How digital device usage is affecting youthThe time we are spending on digital devices is on the rise, and it’s unlikely to slow down any time soon. With more and more apps, games, and social media options, we have all become more dependent on smartphones, tablets, and other electronic devices.